Atherogenic index of plasma and modified indices
Atherogenic index of plasma and modified indices has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, May 31, 2026: “Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiovascular-liver-metabolic multimorbidity: a prospective cohort study from UK Biobank”.
1 paper studies it3 findingsUpdated
See all 1 papers on atherogenic index of plasma and modified indices
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“the risks of progression from the first disease to CLMM increased by 28%, 26%, and 27%”
None of its findings points the other way.
- 1 lab in 1 country
- Humans1
What did studies of atherogenic index of plasma and modified indices find?
1Studies of atherogenic index of plasma and modified indices measured one outcome, Cardiovascular-liver-metabolic multimorbidity risk prediction.
Cardiovascular-liver-metabolic multimorbidity risk prediction
upin humans1
1 study
Cardiovascular-liver-metabolic multimorbidity risk prediction
upin humans1
Atherogenic index of plasma and modified indices are linked with better cardiovascular-liver-metabolic multimorbidity risk prediction in humans (added to risk prediction, assessed by C-index, NRI and IDI).
“All indices improved predictive performance, with AIP-BRI and AIP-BMI showing the highest overall performance”
Humansadded to risk prediction, assessed by C-index, NRI and IDIn = 370,258
Cardiovascular diabetology
What is atherogenic index of plasma and modified indices linked with?
2Studies link atherogenic index of plasma and modified indices with 2 measures: transition from healthy state to first cardiovascular-liver-metabolic disease and progression from first cardiovascular-liver-metabolic disease to multimorbidity.
Transition from healthy state to first cardiovascular-liver-metabolic disease
upin humans1
1 study
Transition from healthy state to first cardiovascular-liver-metabolic disease
upin humans1
Atherogenic index of plasma and modified indices are linked with a higher risk of transition from healthy state to first cardiovascular-liver-metabolic disease in humans (per 1-SD increase in each index) (38%, 36%, and 37% increase per 1-SD increase in each index).
“Per 1-SD increase in each index, the risks of transition from a healthy state to the first CLM disease increased by 38%, 36%, and 37%”
Humansper 1-SD increase in each indexmedian 16.0-year follow-upn = 370,258
Cardiovascular diabetology
More on Transition from healthy state to first cardiovascular-liver-metabolic disease
Progression from first cardiovascular-liver-metabolic disease to multimorbidity
upin humans1
1 study
Progression from first cardiovascular-liver-metabolic disease to multimorbidity
upin humans1
Atherogenic index of plasma and modified indices are linked with a higher risk of progression from first cardiovascular-liver-metabolic disease to multimorbidity in humans (per 1-SD increase in each index) (28%, 26%, and 27% increase per 1-SD increase in each index).
“the risks of progression from the first disease to CLMM increased by 28%, 26%, and 27%”
Humansper 1-SD increase in each indexmedian 16.0-year follow-upn = 370,258
Cardiovascular diabetology
More on Progression from first cardiovascular-liver-metabolic disease to multimorbidity